December 1, 2021

East Valley Times

Complete News World

United States: The FDA has approved the Pfizer vaccine for children 5-11 years of age

About 28 million children in this group are eligible for Pfizer’s pediatric dose (Photo: REUTERS)

Food and Drug Administration (FDA) Of the United States recognized today Pfizer-BioNTech’s corona virus vaccine for emergency use in children 5-11 years of age.

This is an action that creates Great Anticipation Among the millions of families who want to protect some of the remaining Americans to be vaccinated: About 28 million children in this group are eligible for Pfizer’s pediatric dose., Which is one-third used by adults, With two injections at three-week intervals.

“As a mother and doctor, I know parents, caregivers, school staff and children are waiting for today’s approval,” said the Acting FDA Director. Janet Woodcock, This is a statement. “Vaccination of young children against COVID-19 will bring us closer to a return to normal.”

After this operation, the Centers for Disease Control and Prevention (CDC) should now give the final green light to the operation. With this latest approval, children between the ages of 5 and 11 are expected in the United States in the coming days They can start vaccinating from Wednesday, November 3rd. The first children will be fully preserved at Christmas.

On October 26, the Medical Council of U.S. Government Advisers voted Recommend approval for the Pfizer Covit-19 vaccine for children 5 to 11 years of age.

States are preparing to distribute vaccines - in bottles with orange caps, to differentiate them from adult drugs - as soon as the government gives the green light (Photo: REUTERS)
States are preparing to distribute vaccines – in bottles with orange caps, to differentiate them from adult drugs – as soon as the government gives the green light (Photo: REUTERS)

When I hear about children being admitted to the ICU, having long-term results after their covia disease, and infant mortality, it is clear to me that the benefits outweigh the risks.Amanda Cohn of the CDC, who voted in favor, said. With 17 votes in favor, one did not vote.

See also  US: Experts recommend Pfizer vaccine to FDA for children 5 to 11 years of age

This was revealed in a study conducted with primary school children Pfizer vaccines prevent symptomatic infections in 91% of cases, Although this is about one-third of the dose that adolescents and adults receive.

In a preliminary study last week, FDA officials said the risk of a very unusual side effect of protection would be “very high” In almost all infectious conditions.

The risk of acute COVID-19 is lower in children than in adults, Cases have been reported in people between the ages of five and 11 in more than 8,300 hospitals. One-third of that required intensive treatment. And nearly 100 deaths, said Dr. Peter Marx, FDA vaccination chairman.

Although the risk of severe COVID-19 is lower in children than in adults, cases have been reported between the ages of five and 11, and more than 8,300 have been hospitalized (Photo: REUTERS)
Although the risk of severe COVID-19 is lower in children than in adults, cases have been reported between the ages of five and 11, and more than 8,300 have been hospitalized (Photo: REUTERS)

“Epidemics have led to the closure of many schools and disrupted the education and socialization of children.” Added.

I would like to admit that there are strong feelingsMarx said among the public both for and against the vaccine. He added that there will be a discussion on scientific data.The vaccine is not in the orders, it is associated with other organizations outside the FDA”.

States are preparing to distribute vaccines – in bottles with orange caps, to differentiate them from the adult dose – as soon as the government gives the green light. More than 25,000 pediatricians and other primary care providers have declared themselves vaccine providers.

(With information from AP, AFP and EFE)

See also  The government-sponsored law was suspended on October 17

Continue reading: